Experience With a Pediatric Summer Intensive Therapy Program

The Experience of Participating in a Pediatric Summer Intensive Therapy Program--A Mixed Methods Study

The purpose of this study is to explore the lived experiences of children with neurodevelopmental diagnoses and their caregivers with an intensive model of therapy. Children will receive usual care during the summer intensive program and the investigators will access medical records to assess effectiveness. Children and caregivers will also be asked to participate in semi-structured interviews upon the completion of the episode of care.

Study Overview

• Status: Completed
• Conditions: Neurodevelopmental Disorders
• Intervention / Treatment: Other: Intensive therapy program

Detailed Description

The purpose of this study is to explore the lived experiences of children with neurodevelopmental diagnoses and their caregivers with an intensive model of therapy. Research questions include: 1.) What are the perceptions of children and caregivers about intensive therapy after participating in multiple intensive therapy episodes over time? 2.) Why do caregivers choose to continue with an intensive model of therapy periodically for their child with neurodevelopmental diagnoses? 3.) What were the outcomes for children with neurodevelopmental disabilities participating in an episode of intensive therapy? Children will receive usual care during the summer intensive program and the investigators will access medical records to assess effectiveness. Children and caregivers will also be asked to participate in semi-structured interviews upon the completion of the episode of care.

• Study Type: Observational
• Enrollment (Actual): 13

Contacts and Locations

Study Locations

• United States
  • Missouri
    • Columbia, Missouri, United States, 65211
      • University of Missouri Healthcare Children's Therapy Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 4 years to 15 years (Child)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Children 4-15 years old with neurodevelopmental diagnoses and scheduled for an intensive therapy program over the summer.

Description

Inclusion Criteria:

• Children receiving therapy through the Children's Therapy Center's Tiger Intensive Program and their caregivers from May 24 to August 13 2021.

Exclusion Criteria:

• n/a

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Semi-structured interviews	Upon completion of the program, children and caregivers will participate in an interview about their experience	at discharge assessed up to 10 days
Canadian Occupational Performance Measure	Individualized client-centered performance measure	measured at discharge 4 weeks after enrollment

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Lower extremity passive range of motion	Measured at ankle, knee, and hip with goniometer	Measured at day 1 and discharge 4 weeks later
Change in Thomas Test	Hip flexor length test	Measured at day 1 and discharge 4 weeks later
Change in popliteal angle	Hamstring length test	Measured at day 1 and discharge 4 weeks later
Change in Gastrocnemius muscle length	Measured with goniometer	Measured at day 1 and discharge 4 weeks later
Change in Kids Bestest	Balance measure for pediatric patients	Measured at day 1 and discharge 4 weeks later
Change in m-CTSIB	Balance measure	Measured at day 1 and discharge 4 weeks later
Change in Early Clinical Assessment of Balance	Balance measure	Measured at day 1 and discharge 4 weeks later
Change in Segmental Assessment of Trunk Control (SATCO)	Measurement of trunk control	Measured at day 1 and discharge 4 weeks later
Change in Edinburgh Visual Gait Scale	Observational Gait measure	Measured at day 1 and discharge 4 weeks later
Change in Timed Up and Down Stairs	Measure of stair performance	Measured at day 1 and discharge 4 weeks later
Change in Timed on and off the floor	Measure of transition from floor to standing	Measured at day 1 and discharge 4 weeks later
Change in 6 minute walk test	Measure of walking performance	Measured at day 1 and discharge 4 weeks later
Change in Peds QL	Pediatric quality of life measure	Measured at day 1 and discharge 4 weeks later
Change in GOAL	patient reported measure of function mobility	Measured at day 1 and discharge 4 weeks later
Change in Pediatric Evaluation of Disability Inventory	Measure of amount of disability	Measured at day 1 and discharge 4 weeks later
Pediatric Balance Scale	Measure of balance	Measured at day 1 and discharge 4 weeks later

Collaborators and Investigators

• Sponsor: University of Missouri-Columbia

Study record dates

Study Major Dates

• Study Start (Actual): May 24, 2021
• Primary Completion (Actual): September 1, 2021
• Study Completion (Actual): October 1, 2021

Study Registration Dates

• First Submitted: April 29, 2021
• First Submitted That Met QC Criteria: May 12, 2021
• First Posted (Actual): May 18, 2021

Study Record Updates

• Last Update Posted (Actual): March 28, 2022
• Last Update Submitted That Met QC Criteria: March 24, 2022
• Last Verified: March 1, 2022

More Information

Terms related to this study

• Keywords: pediatric rehabilitation; intensive therapy
• Additional Relevant MeSH Terms: Mental Disorders; Neurodevelopmental Disorders
• Other Study ID Numbers: 2058022

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No